Phillip Rosen Patient Friend

How did you get involved with the MMRF? 

My wife, Martina, works for Johnson & Johnson and was on the 2019 Team. I came to Vermont to see her off and was so impressed with the event that I applied to ride in 2021. I joined again in 2023 and am excited to return in 2024 this time to California Wine Country.

Why is participating in the MMRF Road to Victories ride important to you? 

I ride to honor my colleague, Tom Fadden. Tom was diagnosed back in 2019. He has been an inspiration to watch. Tom has shown grit and strength during his journey.

After 38 years of cycling, being involved in an event where you get to help others and raise research dollars to help people live longer and better lives while doing something you love is a win/win in my book. 

What does your training regimen for this event look like?

I am definitely behind schedule with my training compared to last year, but I’ll get there. We typically ride 3 x per week with one of the rides in the hills north of Columbus, Ohio (our ski area). Our hills are short, but they can be 10-16% grades. The mileage is around 130 miles per week.

Who/what inspires you?

The patients that we ride with, Jeff, Andy, Richard, Brian, Paul, Fred, Tim, and Jamie. They impress the hell out of me. 

Have you participated in previous MMRF events? If so, which/when? 

This will be my third event with R2V, I’ve participated in the ride the last two years in Maine and Oregon.

Anything additional to add? 

I am so excited to take on this challenge with such great teammates and support. Thank you to Suzie and the MMRF Team, Backroads, and Johnson & Johnson for their financial support, making sure that 100% of our fundraising dollars go to the foundation’s mission.

https://give.themmrf.org/fundraiser/5382135

Sorry, there are no posts from this member.
The Multiple Myeloma Research Foundation (MMRF) is the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient. We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients. To learn more, visit www.themmrf.org.

Learn More

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more About Johnson & Johnson inovative medicine Learn more About Johnson & Johnson Follow us on @JanssenUS And @JNJInnovMed